Trial intelligence / Profile preview

Local fibrinogen administration for postoperative bleeding in CABG patients

IRCT201510222804N9Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Sep 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of Fibrinogen human in coronary arteriosclerosis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2015; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on IRCT201510222804N9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201510222804N9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call